Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | COVID-19 | Research article

Seasonal COVID-19 surge related hospital volumes and case fatality rates

Authors: Joseph E. Ebinger, Roy Lan, Matthew Driver, Nancy Sun, Patrick Botting, Eunice Park, Tod Davis, Margo B. Minissian, Bernice Coleman, Richard Riggs, Pamela Roberts, Susan Cheng

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Background

Seasonal and regional surges in COVID-19 have imposed substantial strain on healthcare systems. Whereas sharp inclines in hospital volume were accompanied by overt increases in case fatality rates during the very early phases of the pandemic, the relative impact during later phases of the pandemic are less clear. We sought to characterize how the 2020 winter surge in COVID-19 volumes impacted case fatality in an adequately-resourced health system.

Methods

We performed a retrospective cohort study of all adult diagnosed with COVID-19 in a large academic healthcare system between August 25, 2020 to May 8, 2021, using multivariable logistic regression to examine case fatality rates across 3 sequential time periods around the 2020 winter surge: pre-surge, surge, and post-surge. Subgroup analyses of patients admitted to the hospital and those receiving ICU-level care were also performed. Additionally, we used multivariable logistic regression to examine risk factors for mortality during the surge period.

Results

We studied 7388 patients (aged 52.8 ± 19.6 years, 48% male) who received outpatient or inpatient care for COVID-19 during the study period. Patients treated during surge (N = 6372) compared to the pre-surge (N = 536) period had 2.64 greater odds (95% CI 1.46–5.27) of mortality after adjusting for sociodemographic and clinical factors. Adjusted mortality risk returned to pre-surge levels during the post-surge period. Notably, first-encounter patient-level measures of illness severity appeared higher during surge compared to non-surge periods.

Conclusions

We observed excess mortality risk during a recent winter COVID-19 surge that was not explained by conventional risk factors or easily measurable variables, although recovered rapidly in the setting of targeted facility resources. These findings point to how complex interrelations of population- and patient-level pandemic factors can profoundly augment health system strain and drive dynamic, if short-lived, changes in outcomes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Anesi GL, Liu VX, Gabler NB, Delgado MK, Kohn R, Weissman GE, Bayes B, Escobar GJ, Halpern SD. Associations of intensive care unit capacity strain with disposition and outcomes of patients with sepsis presenting to the emergency department. Ann Am Thorac Soc. 2018;15(11):1328–35.CrossRef Anesi GL, Liu VX, Gabler NB, Delgado MK, Kohn R, Weissman GE, Bayes B, Escobar GJ, Halpern SD. Associations of intensive care unit capacity strain with disposition and outcomes of patients with sepsis presenting to the emergency department. Ann Am Thorac Soc. 2018;15(11):1328–35.CrossRef
2.
go back to reference Eriksson CO, Stoner RC, Eden KB, Newgard CD, Guise JM. The Association between hospital capacity strain and inpatient outcomes in highly developed countries: a systematic review. J Gen Intern Med. 2017;32(6):686–96.CrossRef Eriksson CO, Stoner RC, Eden KB, Newgard CD, Guise JM. The Association between hospital capacity strain and inpatient outcomes in highly developed countries: a systematic review. J Gen Intern Med. 2017;32(6):686–96.CrossRef
3.
go back to reference Block BL, Martin TM, Boscardin WJ, Covinsky KE, Mourad M, Hu LL, Smith AK. Variation in COVID-19 mortality across 117 US hospitals in high- and low-burden settings. J Hosp Med. 2021;16(4):215–8.CrossRef Block BL, Martin TM, Boscardin WJ, Covinsky KE, Mourad M, Hu LL, Smith AK. Variation in COVID-19 mortality across 117 US hospitals in high- and low-burden settings. J Hosp Med. 2021;16(4):215–8.CrossRef
4.
go back to reference Gupta S, Hayek SS, Wang W, Chan L, Mathews KS, Melamed ML, Brenner SK, Leonberg-Yoo A, Schenck EJ, Radbel J, et al. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med. 2020;180(11):1436–47.CrossRef Gupta S, Hayek SS, Wang W, Chan L, Mathews KS, Melamed ML, Brenner SK, Leonberg-Yoo A, Schenck EJ, Radbel J, et al. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med. 2020;180(11):1436–47.CrossRef
5.
go back to reference Karaca-Mandic P, Sen S, Georgiou A, Zhu Y, Basu A: Association of COVID-19-Related Hospital Use and Overall COVID-19 Mortality in the USA. J Gen Intern Med. 2020; 1–3. Karaca-Mandic P, Sen S, Georgiou A, Zhu Y, Basu A: Association of COVID-19-Related Hospital Use and Overall COVID-19 Mortality in the USA. J Gen Intern Med. 2020; 1–3.
7.
go back to reference Janke AT, Mei H, Rothenberg C, Becher RD, Lin Z, Venkatesh AK. Analysis of hospital resource availability and COVID-19 mortality across the United States. J Hosp Med. 2021;16(4):211–4.CrossRef Janke AT, Mei H, Rothenberg C, Becher RD, Lin Z, Venkatesh AK. Analysis of hospital resource availability and COVID-19 mortality across the United States. J Hosp Med. 2021;16(4):211–4.CrossRef
8.
go back to reference Ledford H. Why do COVID death rates seem to be falling? Nature. 2020;587(7833):190–2.CrossRef Ledford H. Why do COVID death rates seem to be falling? Nature. 2020;587(7833):190–2.CrossRef
10.
go back to reference SeyedAlinaghi S, Mirzapour P, Dadras O, Pashaei Z, Karimi A, MohsseniPour M, Soleymanzadeh M, Barzegary A, Afsahi AM, Vahedi F, et al. Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review. Eur J Med Res. 2021;26(1):51.CrossRef SeyedAlinaghi S, Mirzapour P, Dadras O, Pashaei Z, Karimi A, MohsseniPour M, Soleymanzadeh M, Barzegary A, Afsahi AM, Vahedi F, et al. Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review. Eur J Med Res. 2021;26(1):51.CrossRef
11.
go back to reference Moriyama M, Hugentobler WJ, Iwasaki A. Seasonality of respiratory viral infections. Ann Rev Virol. 2020;7(1):83–101.CrossRef Moriyama M, Hugentobler WJ, Iwasaki A. Seasonality of respiratory viral infections. Ann Rev Virol. 2020;7(1):83–101.CrossRef
12.
go back to reference van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009;47(6):626–33.CrossRef van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009;47(6):626–33.CrossRef
13.
go back to reference Kleinpell R, Ferraro DM, Maves RC, Kane Gill SL, Branson R, Greenberg S, Doersam JK, Raman R, Kaplan LJ. Coronavirus disease 2019 pandemic measures: reports from a national survey of 9,120 ICU clinicians. Crit Care Med. 2020;48(10):e846–55.CrossRef Kleinpell R, Ferraro DM, Maves RC, Kane Gill SL, Branson R, Greenberg S, Doersam JK, Raman R, Kaplan LJ. Coronavirus disease 2019 pandemic measures: reports from a national survey of 9,120 ICU clinicians. Crit Care Med. 2020;48(10):e846–55.CrossRef
14.
go back to reference Chokshi DA, Katz MH. Emerging lessons from COVID-19 response in New York City. JAMA. 2020;323(20):1996–7.CrossRef Chokshi DA, Katz MH. Emerging lessons from COVID-19 response in New York City. JAMA. 2020;323(20):1996–7.CrossRef
15.
go back to reference Keeley C, Jimenez J, Jackson H, Boudourakis L, Salway RJ, Cineas N, Villanueva Y, Bell D, Wallach AB, Boyle Schwartz D, et al. Staffing up for the surge: expanding the New York City Public Hospital workforce during the COVID-19 pandemic. Health Aff (Millwood). 2020;39(8):1426–30.CrossRef Keeley C, Jimenez J, Jackson H, Boudourakis L, Salway RJ, Cineas N, Villanueva Y, Bell D, Wallach AB, Boyle Schwartz D, et al. Staffing up for the surge: expanding the New York City Public Hospital workforce during the COVID-19 pandemic. Health Aff (Millwood). 2020;39(8):1426–30.CrossRef
16.
go back to reference Argenziano MG, Bruce SL, Slater CL, Tiao JR, Baldwin MR, Barr RG, Chang BP, Chau KH, Choi JJ, Gavin N, et al. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. Bmj. 1996;2020:m369. Argenziano MG, Bruce SL, Slater CL, Tiao JR, Baldwin MR, Barr RG, Chang BP, Chau KH, Choi JJ, Gavin N, et al. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. Bmj. 1996;2020:m369.
17.
go back to reference Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, et al. Remdesivir for the treatment of Covid-19—final report. N Engl J Med. 2020;383(19):1813–26.CrossRef Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, et al. Remdesivir for the treatment of Covid-19—final report. N Engl J Med. 2020;383(19):1813–26.CrossRef
18.
go back to reference Rebmann T, Alvino RT, Holdsworth JE. Availability and crisis standards of care for personal protective equipment during fall 2020 of the COVID-19 pandemic: a national study by the APIC COVID-19 task force. Am J Infect Control. 2021;49(6):657–62.CrossRef Rebmann T, Alvino RT, Holdsworth JE. Availability and crisis standards of care for personal protective equipment during fall 2020 of the COVID-19 pandemic: a national study by the APIC COVID-19 task force. Am J Infect Control. 2021;49(6):657–62.CrossRef
19.
go back to reference Rebmann T, Vassallo A, Holdsworth JE. Availability of personal protective equipment and infection prevention supplies during the first month of the COVID-19 pandemic: a national study by the APIC COVID-19 task force. Am J Infect Control. 2021;49(4):434–7.CrossRef Rebmann T, Vassallo A, Holdsworth JE. Availability of personal protective equipment and infection prevention supplies during the first month of the COVID-19 pandemic: a national study by the APIC COVID-19 task force. Am J Infect Control. 2021;49(4):434–7.CrossRef
20.
go back to reference Rosenthal N, Cao Z, Gundrum J, Sianis J, Safo S. Risk factors associated with in-hospital mortality in a US national sample of patients with COVID-19. JAMA Netw Open. 2020;3(12):e2029058.CrossRef Rosenthal N, Cao Z, Gundrum J, Sianis J, Safo S. Risk factors associated with in-hospital mortality in a US national sample of patients with COVID-19. JAMA Netw Open. 2020;3(12):e2029058.CrossRef
21.
go back to reference Cardemil CV, Dahl R, Prill MM, Cates J, Brown S, Perea A, Marconi V, Bell L, Rodriguez-Barradas MC, Rivera-Dominguez G, et al. COVID-19-related hospitalization rates and severe outcomes among veterans from 5 veterans affairs medical centers: hospital-based surveillance study. JMIR Public Health Surveill. 2021;7(1):e24502.CrossRef Cardemil CV, Dahl R, Prill MM, Cates J, Brown S, Perea A, Marconi V, Bell L, Rodriguez-Barradas MC, Rivera-Dominguez G, et al. COVID-19-related hospitalization rates and severe outcomes among veterans from 5 veterans affairs medical centers: hospital-based surveillance study. JMIR Public Health Surveill. 2021;7(1):e24502.CrossRef
22.
go back to reference Bassett MT, Chen JT, Krieger N. Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: a cross-sectional study. PLoS Med. 2020;17(10):e1003402.CrossRef Bassett MT, Chen JT, Krieger N. Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: a cross-sectional study. PLoS Med. 2020;17(10):e1003402.CrossRef
23.
go back to reference Roth GA, Emmons-Bell S, Alger HM, Bradley SM, Das SR, de Lemos JA, Gakidou E, Elkind MSV, Hay S, Hall JL, et al. Trends in patient characteristics and COVID-19 in-hospital mortality in the United States during the COVID-19 pandemic. JAMA Netw Open. 2021;4(5):e218828–e218828.CrossRef Roth GA, Emmons-Bell S, Alger HM, Bradley SM, Das SR, de Lemos JA, Gakidou E, Elkind MSV, Hay S, Hall JL, et al. Trends in patient characteristics and COVID-19 in-hospital mortality in the United States during the COVID-19 pandemic. JAMA Netw Open. 2021;4(5):e218828–e218828.CrossRef
24.
go back to reference Vahidy FS, Drews AL, Masud FN, Schwartz RL, Askary BB, Boom ML, Phillips RA. Characteristics and outcomes of COVID-19 patients during initial peak and resurgence in the houston metropolitan area. JAMA. 2020;324(10):998–1000.CrossRef Vahidy FS, Drews AL, Masud FN, Schwartz RL, Askary BB, Boom ML, Phillips RA. Characteristics and outcomes of COVID-19 patients during initial peak and resurgence in the houston metropolitan area. JAMA. 2020;324(10):998–1000.CrossRef
25.
go back to reference Bansal S, Roy M, Chatterjee T, Roy AK. Deaths due to delayed presentation to the hospital from fear of contracting COVID-19 during lockdown period: a tertiary care center experience. J Commun Hosp Intern Med Perspect. 2021;11(3):299–301.CrossRef Bansal S, Roy M, Chatterjee T, Roy AK. Deaths due to delayed presentation to the hospital from fear of contracting COVID-19 during lockdown period: a tertiary care center experience. J Commun Hosp Intern Med Perspect. 2021;11(3):299–301.CrossRef
27.
go back to reference Baugh JJ, White BA, McEvoy D, Yun BJ, Brown DFM, Raja AS, Dutta S. The cases not seen: patterns of emergency department visits and procedures in the era of COVID-19. Am J Emerg Med. 2021;46:476–81.CrossRef Baugh JJ, White BA, McEvoy D, Yun BJ, Brown DFM, Raja AS, Dutta S. The cases not seen: patterns of emergency department visits and procedures in the era of COVID-19. Am J Emerg Med. 2021;46:476–81.CrossRef
28.
go back to reference Asch DA, Sheils NE, Islam MN, Chen Y, Werner RM, Buresh J, Doshi JA. Variation in US hospital mortality rates for patients admitted with COVID-19 during the first 6 months of the pandemic. JAMA Intern Med. 2021;181(4):471–8.CrossRef Asch DA, Sheils NE, Islam MN, Chen Y, Werner RM, Buresh J, Doshi JA. Variation in US hospital mortality rates for patients admitted with COVID-19 during the first 6 months of the pandemic. JAMA Intern Med. 2021;181(4):471–8.CrossRef
29.
go back to reference Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020. Ann Intern Med. 2021; 174(9):1240–1251. Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020. Ann Intern Med. 2021; 174(9):1240–1251.
Metadata
Title
Seasonal COVID-19 surge related hospital volumes and case fatality rates
Authors
Joseph E. Ebinger
Roy Lan
Matthew Driver
Nancy Sun
Patrick Botting
Eunice Park
Tod Davis
Margo B. Minissian
Bernice Coleman
Richard Riggs
Pamela Roberts
Susan Cheng
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
COVID-19
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07139-2

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.